Your browser is no longer supported. Please, upgrade your browser.
NARI Inari Medical, Inc. daily Stock Chart
Inari Medical, Inc.
Index- P/E770.00 EPS (ttm)0.08 Insider Own4.60% Shs Outstand50.14M Perf Week12.25%
Market Cap3.24B Forward P/E- EPS next Y-0.37 Insider Trans0.00% Shs Float30.55M Perf Month36.03%
Income3.90M PEG- EPS next Q-0.18 Inst Own41.80% Short Float0.41% Perf Quarter-
Sales71.10M P/S45.61 EPS this Y88.30% Inst Trans- Short Ratio0.26 Perf Half Y-
Book/sh- P/B- EPS next Y0.00% ROA- Target Price53.67 Perf Year-
Cash/sh0.65 P/C100.09 EPS next 5Y- ROE- 52W Range39.55 - 65.49 Perf YTD52.15%
Dividend- P/FCF- EPS past 5Y- ROI-3.00% 52W High-1.24% Beta-
Dividend %- Quick Ratio5.50 Sales past 5Y- Gross Margin89.20% 52W Low63.54% ATR4.03
Employees240 Current Ratio6.10 Sales Q/Q291.30% Oper. Margin8.60% RSI (14)70.10 Volatility7.59% 8.47%
OptionableNo Debt/Eq- EPS Q/Q533.50% Profit Margin5.40% Rel Volume0.68 Prev Close64.61
ShortableYes LT Debt/Eq- EarningsAug 11 AMC Payout0.00% Avg Volume483.43K Price64.68
Recom2.30 SMA2017.47% SMA5027.32% SMA20027.73% Volume332,379 Change0.11%
Jun-19-20Initiated Canaccord Genuity Buy
Jun-16-20Initiated Wells Fargo Equal Weight $49
Jun-16-20Initiated Morgan Stanley Equal-Weight $52
Jun-16-20Initiated BofA/Merrill Neutral $56
Jul-29-20 04:01PM  
Jul-28-20 04:01PM  
Jul-24-20 10:06AM  
Jun-15-20 04:43PM  
Jun-02-20 09:30AM  
May-27-20 12:48PM  
May-22-20 12:40PM  
May-21-20 10:48PM  
Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It produces ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.